2John B. Combining insulin and oral agents. Am J Med, 2000,108(6A):23S-32S
3Bell PM, Hadden DR. Metformin. Endocrinol Metab Clin North Am, 1997,26(3): 523-527
4de Fronzo RA, Goodman AM, and the Multicenter Metformin Study Group. Efficacy ofmetformin in patients with non-insulin-dependent diabetes mellitus.N Engl J Med,1995,333(9):541-549
5United Kingdom Prospective Diabetes Study( UKPDS) Group. UKPDS 28: a randomizedtrial of efficacy of early addition of metformin in sulfonylurea type 2 diabetes. DiabeteCare,1998,21(1):87-92
6Hermann LS, Schersten B, Bitzen PO, et al. Therapeutic comparison of metformin andsulfonylurea, alone and in various combinations: a double-blind controlled study. DiabetesCare, 1994,17(10):1100-1109
7Chiasson JL, Josse AG, Hunt JA, et al. The efficacy of acarbose in the treatment ofpatients with non-insulin-dependent diabetes mellitus. Ann Intern Med, 1994,121(5):928-935
9Horton ES, Whitehouse F, Ghazzi MN, et al. Troglitazone in combination withsulfonylurea restores glycemic control in patients with type 2 diabetes. Diabetes Care,1998,21(12):1462-1469
10Mathisen A, Geerloff J, Houser V. The effect of pioglitazone on glucose controland lipid profile in patients with type 2 diabetes(Abastract). Diabetes, 1999,48(Suppl 1):A102
二级参考文献6
1Porter L E,Freed M I,Jones N P,et al.Rosiglitazone improves β-cell function as measured by proinsulin/insulin ratio in patients with type 2 diabetes[].Diabetes.2000
2Rubin C,Egan J,Schneider R.Combination therapy with pioglitazone and insulin in patients with type 2 diabetes[].Diabetes.1999
3Miyazaki Y,Mahankali A,Matsuda M,et al.Effect of Pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus[].Diabetes.2000
4Spiegelman BM.PPARγadipogenic regulator and thiozolidinedione receptor[].Diabetes.1998
